http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-009695-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_078c0aa81c501a349e6fb5f5bac0c08b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761054c76a6214c5471092c6dd694b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7b7525bc7f402fa487af27ca49389e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98cce3f4f408b1df93a0f03e2f3afa6e
publicationDate 2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-009695-B1
titleOfInvention GRANULES CONTAINING VENLAFAXIN HYDROCHLORIDE
abstract The invention relates to granules containing venlafaxine hydrochloride, and the method of their preparation. The granules in accordance with the invention have a shape close to spherical, and include pharmaceutically active venlafaxine hydrochloride in an amount of a maximum of 80 wt.%, In addition, from 10 to 60 wt.% Sodium chloride and / or potassium chloride, from 10 to 60 wt.% microcrystalline cellulose and possibly other pharmaceutically acceptable excipients and / or additives that contribute to granulation. These granules are particularly suitable for coating with a layer that provides controlled release of the active ingredient.
priorityDate 2003-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03041692-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1331003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03082261-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414028195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6446646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452250309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447963314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449000177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448748630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505829

Total number of triples: 53.